The Medicines and Healthcare products Regulatory Agency has authorised the use of Wegovy weight-loss tablets for adults meeting specific BMI and health criteria. While the medication is not yet available on the NHS, this approval allows eligible patients to access the treatment via private prescription - marking the first time a GLP-1 receptor agonist tablet has been cleared for use in Europe.